FORM4API
ExploreSearch any ticker for its insider tradesFilingsThe newest Form 4 filings, market-wideForm 144Intent to sell, filed before the trade13F FilersInstitutional 13F-HR filers by AUMSignalsCluster buy & sell signalsScreenerFilter trades by code, size & returnCongressSTOCK Act trades disclosed by Congress
PricingDocs
SEC Form 4 explainedSEC Form 144 explained13F-HR filings explainedCluster buy signals10b5-1 trading plans
All guides →
Sign inGet a keyDashboard

Company profile

Kyverna Therapeutics, Inc. Insider Trading

KYTX

Every SEC Form 4 insider trading filing for Kyverna Therapeutics, Inc. (KYTX) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
CIK
0001994702
Filings
41
Insiders
34
Last filing
2026-05-27
SEC EDGAR ↗Yahoo Finance ↗Finviz ↗Stock Analysis ↗

Activity summary

No insider transactions in the last 30 days. The most recent was on May 27, 2026, when Fred E Cohen bought 5,093 shares. 41 filings from 34 insiders are on record below.

Three year balance

Buy and sell value by quarter, Q1 24 to Q2 26. Kyverna Therapeutics, Inc. insiders are net buyers across the period shown.

PurchasesSales
$45.4MQ1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $45.4M.

No insider activity recorded for KYTX in the last 90 days.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValueReturn
May 27, 2026Fred E CohenKYTX
Award
5,093——-0.2% 3m
May 27, 2026Fred E CohenKYTX
Award
20,582——-0.2% 3m
May 27, 2026Ian T ClarkKYTX
Award
5,093——-0.2% 3m
May 27, 2026Ian T ClarkKYTX
Award
20,582——-0.2% 3m
May 27, 2026Beth C SeidenbergKYTX
Award
5,093——-0.2% 3m

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=KYTX" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Westlake BioPartners Opportunity Fund I, L.P.10% owner1 filing+$1000K
Beth C Seidenberg1 filing+$1000K
Karen Marie WalkerChief Technology Officer2 filings−$177K
Christi ShawExecutive Chairperson1 filing−$36K

Institutional Ownership

Top 13F-HR holders of Kyverna Therapeutics, Inc. as of 2026-06-30

↓ decreasing
Total reported AUM
$110.3M
QoQ change
-61.4%
Reporting period
2026-06-30
#1
Gilead Sciences, Inc.
CIK 0000882095
$36.8M
4.1M shares
#2
AIGH Capital Management LLC
CIK 0001835943
$18.5M
2.1M shares
#3
BlackRock, Inc.
CIK 0002012383
$16.7M
1.9M shares

Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →

FORM4API

Real-time SEC Form 4, Form 144, 13F-HR and congressional trading data, over a REST API and webhooks.

Data
  • Screener
  • Filings
  • Signals
  • Companies
  • Insiders
  • Congress trades
  • 13F filers
  • Explorer
  • Top insiders
Developers
  • Documentation
  • Insider trading API
  • Python SDK
  • TypeScript SDK
  • MCP server
  • Status
Company
  • Pricing
  • Guides
  • Compare
  • About
  • Data quality
  • Privacy
  • Terms
Form4API, StockholmNot affiliated with the SEC or EDGAR. Data sourced from public EDGAR filings. Not investment advice.

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.

TEAMAtlassian CorpLEGLeggett & Platt IncVZVerizon Communications IncTPLTexas Pacific Land CorpCRMSalesforce, Inc.RCGRENN Fund, Inc.METAMeta Platforms, Inc.ACNAccenture plcPPGPpg Industries IncNFLXNetflix IncCHDChurch & Dwight Co Inc /de/